BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30016493)

  • 1. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
    Barbosa de Souza Rizzo M; Brasilino de Carvalho M; Kim EJ; Rendon BE; Noe JT; Darlene Wise A; Mitchell RA
    QJM; 2018 Nov; 111(11):769-778. PubMed ID: 30016493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin.
    Wang L; Wang C; Tao Z; Zhu W; Su Y; Choi WS
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166695. PubMed ID: 36958712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages.
    Prieto-Lafuente L; Gregory WF; Allen JE; Maizels RM
    J Leukoc Biol; 2009 May; 85(5):844-54. PubMed ID: 19179453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.
    Yaddanapudi K; Putty K; Rendon BE; Lamont GJ; Faughn JD; Satoskar A; Lasnik A; Eaton JW; Mitchell RA
    J Immunol; 2013 Mar; 190(6):2984-93. PubMed ID: 23390297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
    Safi W; Kraus A; Grampp S; Schödel J; Buchholz B
    J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of macrophage migration inhibitory factor in cartilage tissue engineering.
    Fujihara Y; Hikita A; Takato T; Hoshi K
    J Cell Physiol; 2018 Feb; 233(2):1490-1499. PubMed ID: 28574571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
    Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S
    Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis.
    Damle SR; Martin RK; Cross JV; Conrad DH
    Mucosal Immunol; 2017 Jan; 10(1):205-214. PubMed ID: 27049059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
    Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
    Kindt N; Preillon J; Kaltner H; Gabius HJ; Chevalier D; Rodriguez A; Johnson BD; Megalizzi V; Decaestecker C; Laurent G; Saussez S
    J Cancer Res Clin Oncol; 2013 May; 139(5):727-37. PubMed ID: 23354841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.
    Wang Z; Wei M; Wang M; Chen L; Liu H; Ren Y; Shi K; Jiang H
    Inflammation; 2014 Dec; 37(6):2020-9. PubMed ID: 24958012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
    Klemke L; De Oliveira T; Witt D; Winkler N; Bohnenberger H; Bucala R; Conradi LC; Schulz-Heddergott R
    Cell Death Dis; 2021 Feb; 12(2):155. PubMed ID: 33542244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
    Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
    Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
    Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in adjuvant-induced arthritis via inhibition of macrophage inflammatory activation.
    Zhang Z; Zhang R; Li L; Zhu L; Gao S; Lu Q; Gu Y; Zhang Y; Yang H; Hou T; Zhen X; Zheng LT
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):149-157. PubMed ID: 29447014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
    Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
    Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
    Zeng J; Quan J; Xia X
    Mol Med Rep; 2016 Jan; 13(1):174-80. PubMed ID: 26549761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-derived macrophage migration inhibitory factor mediates renal injury in anti-glomerular basement membrane glomerulonephritis.
    Yang H; Li J; Huang XR; Bucala R; Xu A; Lan HY
    Front Immunol; 2024; 15():1361343. PubMed ID: 38846956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.
    Barnes MA; McMullen MR; Roychowdhury S; Madhun NZ; Niese K; Olman MA; Stavitsky AB; Bucala R; Nagy LE
    J Leukoc Biol; 2015 Jan; 97(1):161-9. PubMed ID: 25398607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.